Pembrolizumab vs Telmisartan
Pembrolizumab vs Telmisartan: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Telmisartan.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Telmisartan: Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.
Pharmacokinetics
Half-life: Pembrolizumab — 26 days; Telmisartan — 24 hours.
Chemical Properties
Molecular Formula: Telmisartan — C33H30N4O2.
Molecular Weight: Telmisartan — 514.6230 g/mol.
Type: Pembrolizumab — Antibody; Telmisartan — Small molecule.